Biological computing remains a small research field, but 2026 has broadened both the evidence and the engineering toolkit. Commercial and remotely accessible living-neural platforms now coexist with peer-reviewed work on goal-directed adaptation, supervised temporal generation and three-dimensional neural interfaces.
Learning demonstrations became more varied
The cart-pole organoid study reported feedback-driven improvement in a virtual control task. The PNAS temporal-pattern study trained modular cortical cultures to generate periodic and chaotic signals in closed loop. Together with DishBrain and Brainoware, these results now span several distinct definitions of useful computation.
Neural I/O advanced quickly
3D-MIND distributed recording and stimulation through a cultured three-dimensional network and reported recordings across six months. Separate 2026 papers described a 240-electrode shape-conformal organoid interface and a multilayer mesh MEA for depth-resolved recording. These interface advances attack a central bottleneck. They do not yet establish faster biological computation.
Platforms are becoming accessible
CL1 provides neuron-on-silicon hardware and cloud access. FinalSpark exposes maintained neural organoids remotely. These platforms reduce the wet-lab barrier and make replication by outside groups more plausible.
Commercial claims need matched benchmarks
The Biological Computing Co. is using living neurons as an algorithm-discovery substrate and deploying the result as ordinary software. Its public performance figures remain company evidence. More broadly, energy and speed claims should include the complete hybrid system and a strong electronic baseline performing the same task.
What remains unresolved
Reproducibility, culture-to-culture variance, whole-system energy, useful lifetime, retention and memory portability remain open. A commercially important processor will also need software abstractions that make a variable living substrate predictable enough for developers.
Current judgement
The field has moved beyond a handful of isolated demonstrations into an early platform-and-interface phase. The next decisive step is a replicated workload where a biological subsystem earns a practical advantage on a matched system-level metric.
See the evidence database, benchmarking framework, interface atlas and 2026 research index.